SARS-CoV-2 influenza A influenza B Nucleic Acidum Compositum
Product nomen
HWTS-RT060A-SARS-CoV-2 influenza A influenza B Nucleic Acidum Compositum Detection Kit (Fluorescens PCR)
Epidemiologia
Corona Virus Morbus 2019 (COVID-19) causatur a SARS-CoV-2 quod ad β Coronaviri generis pertinet.COVID-19 acutus est morbus respiratorii infectious et turbae plerumque susceptiva.Nunc, aegros Sars-CoV-2 infecti principale principium contagionis sunt, et aegroti asymptomatici fons contagionis etiam fieri possunt.Ex hodierna investigatione epidemiologica, incubatio periodus est 1-14 dierum, maxime 3-7 dierum.Praecipuae manifestationes febrium, tussis et lassitudo sicca.Pauci aegri symptomata habent ut nasi obstructio, liquescens nasum, faucium, myalgia et diarrhoea.
Influenza est infectio acuta respiratoria ex virus influenza causata.Valde infectiosis et maxime per tussim et sternumentum diffunditur.Solet vere et hieme erumpit.Influenza tria sunt genera, Influenza A (IFV A), Influenza B (IFV B) et Influenza C (IFV C), utraque ad ortomyxoviri familiam pertinent.Influenza A et B, quae simplicia sunt virus segmentorum RNA, sunt principales causae morborum humanorum.Influenza A est morbus infectious respiratorii acutus, cum H1N1, H3N2 et aliis subtypis, facile mutatur.tumultus globalis, "shift" significat mutationem influentiae A, inde in nova virali "subtypo".Influenza B in duas lineas divisa est: Yamagata et Victoria.Influenza B tantum egisse antigenicam habent, et custodias et eliminationes ab humana ratione immune per mutationem evadunt.Sed influenza B virus tardius evolvunt quam influenza humana A, quae etiam infectiones respiratoriae et epidemiae in hominibus causant.
Channel
| FAM | SARS-CoV-2 |
| ROX | IFV B* |
| CY5 | IFV A |
| VIC(HEX) | Internum Imperium genes |
Technical Parameters
| Repono | Liquid: ≤-18℃ In tenebris |
| Lyophilization: ≤30℃ in tenebris | |
| Fasciae vita | Liquid: 9 months |
| Lyophilization: 12 months | |
| Specimen Type | Nasopharyngea swabs, oropharyngea swabs |
| Ct | ≤38 |
| CV | ≤5.0% |
| LoD | 300 Copia/mL |
| Specification | Crux test eventus demonstravit ornamentum coronavirus hominum SARSr- CoV, MERSr-CoV, HcoV-OC43, HcoV-229E, HcoV-HKU1, HCoV-NL63, virus syncytialis respiratorii A et B, parainfluenza virus 1, 2 et 3, rhinovirusA, B, C, adenovirus 1, 2, 3, 4, 5, 7 et 55, metapneumovirus humanus, enterovirus A, B, C, D, virus cytoplasmicum pulmonis humanum, EB virus, boa virus cytomegalovirus, rotavirus; norovirus, mumps virus, varicella zoster virus, Mycoplasma pneumoniae, Chlamydia pneumoniae, Legionella, pertussis, Haemophilus influenzae, Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus pyogenes, Klebsiella pneumoniae, Mycobacterium tuberculosis, Aspergillus fumigatus tuberculosis, Aspergillus fumigatus. inter Pneumocystis yersini et Cryptococcum neoformans. |
| Instrumenta applicabilia: | Per instrumenta amet fluorescentium in foro aequare potest. Acta Biosystems (VII)D Real-time PCR Systems Acta Biosystems (VII)D Fast Verus-Tempus PCR Systems QuantStudio®5 Real-Time PCR Systems SLAN-96P Real-time PCR Systems LightCycler®480 Real-time PCR systema LineGene 9600 Plus Real-time PCR Detection System MA-6000 Real-time Quantitatis Thermal Cycler BioRad CFX96 Real-time PCR System BioRad CFX Opus 96 Real-time PCR System |
Opus O
Optio 1 .
Extraction reagens commendatur: Macro & Micro-test Viralis DNA/RNA Kit (HWTS-3001, HWTS-3004-32, HWTS-3004-48) et Macro & Micro-test Automatica Acido Nucleico Extractor (HWTS-3006).
Optio II.
Commendatur extraction reagens: Acidum nuclei extractio seu Purificatio Reagenti (YDP302) by Tiangen Biotech (Beijing) Co.,Ltd.
